Description
TOLVAHEAL 30 MG
Indications
TOLVAHEAL 30 MG is primarily indicated for the treatment of moderate to severe pain in adults. It is often prescribed in cases where traditional analgesics have proven ineffective. This medication is particularly useful in managing pain associated with conditions such as osteoarthritis, rheumatoid arthritis, and post-operative pain. Additionally, TOLVAHEAL may be utilized in palliative care settings to enhance the quality of life for patients experiencing chronic pain.
Mechanism of Action
The active ingredient in TOLVAHEAL is Tolvaptan, which acts as a selective vasopressin V2 receptor antagonist. By inhibiting the action of vasopressin, TOLVAHEAL promotes aquaresis, or the excretion of free water, leading to a decrease in body fluid volume. This mechanism is particularly beneficial in conditions characterized by fluid overload, such as heart failure and certain forms of kidney disease. The analgesic properties of TOLVAHEAL are attributed to its ability to modulate pain pathways in the central nervous system, thereby reducing the perception of pain.
Pharmacological Properties
TOLVAHEAL exhibits a unique pharmacokinetic profile. After oral administration, Tolvaptan is rapidly absorbed, with peak plasma concentrations typically reached within 2 to 4 hours. The bioavailability of TOLVAHEAL is approximately 60%, and it is primarily metabolized by the liver via cytochrome P450 enzymes, particularly CYP3A4. The elimination half-life of Tolvaptan is around 12 hours, allowing for once-daily dosing in most cases. The drug is excreted mainly through the urine, with a small percentage eliminated in feces.
Contraindications
TOLVAHEAL is contraindicated in patients with a known hypersensitivity to Tolvaptan or any of the excipients in the formulation. Additionally, it should not be used in individuals with severe renal impairment or those who are unable to initiate and maintain adequate fluid intake. Patients with a history of liver disease, particularly those with elevated liver enzymes, should also avoid this medication due to the potential for hepatotoxicity. Pregnant and breastfeeding women should consult their healthcare provider before using TOLVAHEAL.
Side Effects
Like all medications, TOLVAHEAL may cause side effects. Common adverse reactions include dry mouth, increased thirst, and frequent urination. Some patients may experience dizziness or lightheadedness, particularly when standing up quickly. Less common but more serious side effects include liver function abnormalities, electrolyte imbalances, and severe allergic reactions. It is essential for patients to report any unusual symptoms to their healthcare provider promptly. Regular monitoring of liver function tests is recommended during treatment.
Dosage and Administration
The recommended starting dose of TOLVAHEAL for adults is 30 mg taken orally once daily. Depending on the patient’s response and tolerability, the dose may be increased to a maximum of 60 mg per day. It is advisable to take TOLVAHEAL at the same time each day to maintain consistent blood levels of the medication. Patients should be encouraged to drink adequate fluids to prevent dehydration, especially during the initial stages of treatment. Dosage adjustments may be necessary for individuals with hepatic impairment or those taking concomitant medications that affect Tolvaptan metabolism.
Interactions
TOLVAHEAL may interact with other medications, potentially altering its effectiveness or increasing the risk of adverse effects. Strong inhibitors of CYP3A4, such as ketoconazole and erythromycin, may increase Tolvaptan plasma concentrations, necessitating a dose adjustment. Conversely, inducers of CYP3A4, like rifampicin and St. John’s Wort, may decrease Tolvaptan levels, reducing its efficacy. Patients should inform their healthcare provider of all medications, supplements, and herbal products they are taking to avoid potential interactions.
Precautions
Clinical Studies
Conclusion
TOLVAHEAL 30 MG is a valuable option for the management of moderate to severe pain in adults, particularly in cases where conventional analgesics are inadequate. Its unique mechanism of action and pharmacological properties make it an effective choice for pain relief. However, healthcare providers must consider the potential contraindications, side effects, and drug interactions associated with TOLVAHEAL. Regular monitoring and patient education are essential to ensure safe and effective use of this medication.
Important
It is essential to use TOLVAHEAL responsibly and under the supervision of a qualified healthcare provider. Patients should adhere to prescribed dosages and report any side effects or concerns to their doctor. This medication is intended for specific medical conditions and should not be used without proper medical guidance.
